Seeking Alpha

Regeneron Pharmaceuticals (REGN): Q4 EPS of -$0.37 beats by $0.23. Revenue of $123M (-8% Y/Y)...

Regeneron Pharmaceuticals (REGN): Q4 EPS of -$0.37 beats by $0.23. Revenue of $123M (-8% Y/Y) misses by $8M. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)